Traditionally, selected plant sources have been explored for medicines to treat convulsions.
This continues today, especially in countries with low-income rates and poor medical …

This article provides a comprehensive narrative review of the history of antiepileptic drugs
(AEDs) and their development over time. Firstly, it explores the significant role of serendipity …

Over 65 million people suffer from recurrent, unprovoked seizures. The lack of validated
biomarkers specific for myriad forms of epilepsy makes diagnosis challenging. Diagnosis …

Background This study aims to assess knowledge, practices and attitudes of the general
Moroccan population towards epilepsy and to highlight predictive factors. Method A cross …

Background The approval of eslicarbazepine acetate (ESL) by the Food and Drug
Administration (FDA) in 2013 marked an advancement in the treatment of adult patients with …

Epilepsy affects 50 million people worldwide. Nearly 80% of people with epilepsy live in
resource-constrained low-income and middle-income countries. In Asia, which has a …

Introduction: Epilepsy is a group of neurological disorders characterized by recurring
seizures and fits. The Epilepsy genes can be classified into four distinct groups, based on …

Presently, at least 60 million people are suffering from epilepsy worldwide. Although multiple
pharmacological options for treatment exist, about 30% to 40% of these patients are …

Epilepsy, a prevalent neurological disorder, is characterized by chronic seizures resulting
from abnormal electrical activity in the brain. Adequate medical treatment allows roughly …

Background Although epilepsy has been acknowledged as an illness since ancient time, the
public attitude toward epilepsy has not changed drastically due to the lack of appropriate …